This small startup wants to change FDA clinical trials by making control groups unnecessary

chain of paper people

Could a startup founded by two guys in their 20s change the way medical researchers study patients? The Food and Drug Administration is open to the possibility.

Flatiron Health began as a small New York tech company trying to use real-world data from patient electronic medical records to replace more traditional clinical trial data. Then it raised $328 million, launched a modest collaboration with the FDA to study the use of its so-called “real-world” data in 2016, and entered partnerships with just about every major drug firm.

Traditional clinical trials, which generally randomly assign some patients to a control group, are the gold standard for determining that a new medicine is safe and effective for its intended use… . But they don’t always represent what happens to patients in the real world.

Related article:  Seeking answers for sick babies through whole genome sequencing

Zach Weinberg, 32, Flatiron’s co-founder … promised Flatiron will soon publish results showing it is possible to achieve one of the major goals of the field: using data collected from health records to mimic a control group.

That idea is not without controversy, and in emailed responses to questions, the FDA was more tentative about the prospect of perhaps replacing control groups one day.

Read full, original post: Can Roche’s little tech startup help the FDA change clinical trials?

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: How dangerous COVID mutant strains develop

Infographic: How dangerous COVID mutant strains develop

Sometime in 2019, probably in China, SARS CoV-2 figured out a way to interact with a specific "spike" on the ...
Untitled

Philip Njemanze: Leading African anti-GMO activist claims Gates Foundation destroying Nigeria

Nigerian anti-GMO activist, physician, and inventor pushes anti-gay and anti-GMO ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend